UBS Maintains Buy on Ardent Health, Raises Price Target to $13.5

Benzinga Newsdesk www.benzinga.com Positive 79.2%

Neg 0% Neu 0% Pos 79.2%

UBS analyst A.J. Rice maintains Ardent Health (NYSE:ARDT) with a Buy and raises the price target from $13 to $13.5.

Comments

No comments yet. Be the first!